Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name MK-1308
Trade Name
Synonyms MK1308|MK 1308
Drug Descriptions

MK-1308 is a monoclonal antibody that targets CTLA4, potentially resulting in increased anti-tumor immune response and decreased tumor growth (NCI Drug Dictionary).

DrugClasses CTLA4 Antibody 17 Immune Checkpoint Inhibitor 94

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Lenvatinib + MK-1308 + Pembrolizumab Lenvatinib MK-1308 Pembrolizumab 0 1
MK-1308 MK-1308 0 1
MK-1308 + MK-7684 + Pembrolizumab MK-1308 MK-7684 Pembrolizumab 0 1
MK-1308 + Pembrolizumab MK-1308 Pembrolizumab 0 2


Additional content available in CKB BOOST